Editas Medicine (EDIT) Earnings Date & Reports

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

EDIT is expected to report earnings to rise 1.29% to -55 cents per share on April 30

Editas Medicine EDIT Stock Earnings Reports

Q1'25

Est.

$-0.56

Q4'24

Missed

by $0.22

Q3'24

Est.

$-0.75

Q2'24

Missed

by $0.12

Q1'24

Missed

by $0.13

The last earnings report on March 05 showed earnings per share of -55 cents, missing the estimate of -33 cents. With 1.78M shares outstanding, the current market capitalization sits at 97.91M.

View a ticker or compare two or three

Compare

EDIT